deltatrials
Completed NCT00339976

Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis

Ascertainment of Death in ALS Patients

Sponsor: National Institute of Environmental Health Sciences (NIEHS)

Conditions ALS Amyotrophic Lateral Sclerosis
Updated 6 times since 2017 Last updated: Jun 30, 2017 Started: Aug 6, 2002 Completion: Apr 21, 2008

A observational or N/A phase clinical study on ALS and Amyotrophic Lateral Sclerosis, this trial is completed. The trial is conducted by National Institute of Environmental Health Sciences (NIEHS) and has accumulated 6 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Environmental Health Sciences (NIEHS)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Research Triangle Park, United States